[go: up one dir, main page]

BR0308377A - Processo para sìntese de n-aril piperazinas quirais - Google Patents

Processo para sìntese de n-aril piperazinas quirais

Info

Publication number
BR0308377A
BR0308377A BR0308377-2A BR0308377A BR0308377A BR 0308377 A BR0308377 A BR 0308377A BR 0308377 A BR0308377 A BR 0308377A BR 0308377 A BR0308377 A BR 0308377A
Authority
BR
Brazil
Prior art keywords
piperazines
synthesis
chiral
aryl piperazines
aryl
Prior art date
Application number
BR0308377-2A
Other languages
English (en)
Inventor
Gregg Brian Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0308377A publication Critical patent/BR0308377A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

"PROCESSO PARA SìNTESE DE N-ARIL PIPERAZINAS QUIRAIS". A presente invenção refere-se a um processo para formação de N-aril piperazinas com cadeias laterais quirais tendo a estrutura mostrada na fórmula abaixo, e para fabricação de compostos intermediários para as mesmas: Neste processo, quiralidade é introduzida na etapa de formação de anel piperazina e substituição 2-aminopiridila é incorporada via deslocamento. As resultantes piperazinas N,N<39>-dissubstituídas atuam sobre o sistema nervoso central em receptores de 5HT.
BR0308377-2A 2002-03-12 2003-03-10 Processo para sìntese de n-aril piperazinas quirais BR0308377A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36343102P 2002-03-12 2002-03-12
PCT/US2003/007078 WO2003078417A1 (en) 2002-03-12 2003-03-10 Process for synthesizing chiral n-aryl piperazines

Publications (1)

Publication Number Publication Date
BR0308377A true BR0308377A (pt) 2005-01-11

Family

ID=28041762

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308377-2A BR0308377A (pt) 2002-03-12 2003-03-10 Processo para sìntese de n-aril piperazinas quirais

Country Status (23)

Country Link
US (1) US6713626B2 (pt)
EP (1) EP1483255B1 (pt)
JP (1) JP4391241B2 (pt)
KR (1) KR20040105765A (pt)
CN (2) CN1982307A (pt)
AR (1) AR038930A1 (pt)
AT (1) ATE439356T1 (pt)
AU (1) AU2003220094B2 (pt)
BR (1) BR0308377A (pt)
CA (1) CA2477892C (pt)
CR (1) CR7431A (pt)
DE (1) DE60328756D1 (pt)
EC (1) ECSP045290A (pt)
ES (1) ES2329122T3 (pt)
IL (1) IL163827A0 (pt)
MX (1) MXPA04008729A (pt)
NO (1) NO20044050L (pt)
NZ (1) NZ535168A (pt)
RU (1) RU2315762C2 (pt)
TW (1) TW200403231A (pt)
UA (1) UA79273C2 (pt)
WO (1) WO2003078417A1 (pt)
ZA (1) ZA200408202B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
JP5080716B2 (ja) * 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
WO2003078420A2 (en) * 2002-03-12 2003-09-25 Wyeth Process for making chiral 1,4-disubstituted piperazines
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
AU2003220122A1 (en) * 2002-03-12 2003-09-29 Wyeth Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
TW200700413A (en) * 2005-03-01 2007-01-01 Wyeth Corp Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
WO1994024115A1 (en) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Novel piperazine derivative
WO1995033725A1 (en) 1994-06-03 1995-12-14 John Wyeth & Brother Limited Novel processes and intermediates for the preparation of piperazine derivatives
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9413772D0 (en) * 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
GB9514901D0 (en) * 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
JP2000508319A (ja) 1996-04-10 2000-07-04 メルク エンド カンパニー インコーポレーテッド αｖβ３拮抗薬
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents

Also Published As

Publication number Publication date
RU2004130300A (ru) 2005-04-10
US6713626B2 (en) 2004-03-30
ATE439356T1 (de) 2009-08-15
TW200403231A (en) 2004-03-01
RU2315762C2 (ru) 2008-01-27
ES2329122T3 (es) 2009-11-23
NO20044050L (no) 2004-09-24
IL163827A0 (en) 2005-12-18
NZ535168A (en) 2006-03-31
DE60328756D1 (de) 2009-09-24
CA2477892A1 (en) 2003-09-25
MXPA04008729A (es) 2005-07-13
CR7431A (es) 2008-07-29
ZA200408202B (en) 2007-03-28
UA79273C2 (en) 2007-06-11
ECSP045290A (es) 2004-10-26
AR038930A1 (es) 2005-02-02
CN1642936A (zh) 2005-07-20
JP4391241B2 (ja) 2009-12-24
CN1982307A (zh) 2007-06-20
EP1483255B1 (en) 2009-08-12
CA2477892C (en) 2010-11-23
WO2003078417A1 (en) 2003-09-25
CN1304388C (zh) 2007-03-14
AU2003220094B2 (en) 2009-04-23
EP1483255A1 (en) 2004-12-08
US20030187265A1 (en) 2003-10-02
KR20040105765A (ko) 2004-12-16
JP2005526775A (ja) 2005-09-08
AU2003220094A1 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
BR0209241A (pt) Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
BR0308377A (pt) Processo para sìntese de n-aril piperazinas quirais
BR0209580A (pt) Derivados de ciclohexan-1, 4 diamina substituìdos
GT200100160A (es) Derivados 4-fenil-piridina.
BRPI0408347A (pt) derivados de pirimidina
EA200300595A1 (ru) Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
BRPI0500585B8 (pt) processo para a síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
BR0316056A (pt) Processo para a preparação de compostos de pirrolotriazina úteis como inibidores de cinase
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
BRPI0513672A (pt) processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)&#39; [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
ECSP034796A (es) DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA ANTAGONISTAS I MGLUR2
AR029821A1 (es) Decahidro-isoquinolinas, un proceso para su preparacion, composiciones farmaceuticas que las comprenden y el uso de las mismas para la fabricacion de un medicamento
DE69838662D1 (de) Morphinanderivate und ihre medizinische Anwendung
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
BR0312169A (pt) Composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afligido por uma condição patológica ou doença suscpetivel de redução por antagonismo de receptores muscarìnicos m3 e produto de combinação
UY28377A1 (es) Agentes terapeuticos
BR0308315A (pt) Preparação de ácido n1-(2&#39;-piridil)-1,2-propanodiamina sulfâmico e seu uso na sìntese de piperazinas biologicamente ativas
ATE427310T1 (de) Kondensierte bicyclische pyrimidinderivate
BRPI0500590B8 (pt) processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
UY26566A1 (es) Nuevos moduladores alostéricos positivos de receptores de ampa (paarm), procedimientos para su preparación y su utilización como medicamentos.
ATE398614T1 (de) Triazolverbindungen und ihre therapeutische verwendung
BR0017175A (pt) Modificação da torasemida amorfa
BRPI0410613A (pt) preparação de quinoxalinas substituìdas a partir da dianlina com 2,3-diidróxi-1,4-dioxano

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.